According to VistaGen Therapeutics 's latest financial reports the company's current revenue (TTM) is $1.04 M. In 2022 the company made a revenue of -$0.37 M a decrease over the years 2021 revenue that were of $1.51 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.04 M | -386.42% |
2022 | -$0.37 M | -124.07% |
2021 | $1.51 M | 133.46% |
2020 | $0.64 M | |
2019 | N/A | |
2018 | N/A | |
2013 | N/A | -100% |
2012 | $0.66 M | -23.36% |
2011 | $0.87 M | |
2010 | N/A | |
2009 | N/A | |
2008 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | N/A | N/A | ๐บ๐ธ USA |